To determine if umbilical cord plasma erythropoietin (EPO) levels in combination with cord blood gases and Apgar scores can distinguish between subacute and chronic uteroplacental insufficiency.
Intrauterine fetal well being has been traditionally assessed by ultrasound studies and fetal heart rate monitoring. [1] [2] [3] These surveillance methods, however, have not helped decrease the incidence of cerebral palsy. 4, 5 It has been suggested that chronic, rather than subacute or acute, fetal hypoxia is a better predictor of neurologic deficits in the newborn. 6 -11 To improve pregnancy outcomes, investigators have searched for better markers of chronic fetal hypoxia.
Erythropoietin (EPO) is a glycoprotein produced by the fetal kidney and liver, and its production increases only in response to fetal hypoxia. 12 The presence of EPO in fetal blood has been documented as early as the 16th week of gestation. 13 Elevated EPO has been associated with uteroplacental insufficiency, like fetal growth restriction (FGR) 14 and intrauterine fetal hypoxia. 15, 16 A strong correlation between EPO and cord blood gases has also been reported. [17] [18] [19] As an indicator of chronic hypoxia, EPO may prove useful in identifying fetuses at risk for long-term irreversible end organ damage such as cerebral palsy. The purpose of this study was to determine if fetal EPO could provide a better method for identifying infants with chronic uteroplacental insufficiency than cord blood gases and Apgar scores alone.
METHODS
The study protocol was approved by the Institutional Review Board of the University of South Florida College of Medicine. The estimated gestational age of the infants at delivery was 24 to 40 completed weeks, based on menstrual history, early ultrasound examinations, and neonatal evaluations. The diagnosing of abnormal fetal heart rate (FHR) tracings was based on the obstetrician's evaluation of the continuous electronic fetal heart monitoring in labor. The criteria for abnormal FHR tracings were as follows: repetitive late decelerations, repetitive moderate to severe variable decelerations unresponsive to intrauterine resuscitation, and fetal tachycardia with decreased beatto-beat variability in the absence of clinical chorioamnionitis. Unexplained fetal growth restriction was defined as newborn weight less than the 10 percentile for the gestational age 20 in the absence of karyotypic anomalies or infectious etiology. In this study FGR was used as evidence of chronic hypoxia, due to uteroplacental insufficiency. Abnormal FHR tracings during labor were used as evidence of subacute hypoxia. Therefore, the population of 184 infants was di- Original Article
vided into four groups: Appropriate growth for gestational age infants (AGA) with (n ϭ 119) or without (n ϭ 33) normal FHR tracings, and FGR with (n ϭ 16) or without (n ϭ 16) normal FHR tracings. Following delivery, a segment of the umbilical cord was clamped and blood samples were obtained by one of the two co-investigators (A. J. or W. N. S.). Umbilical artery blood was sent for blood gas analysis (IL1306 analyzer; Allied Instrumentation Laboratory; Lexington, MA). Umbilical vein blood was needle-aspirated and immediately transferred into tubes containing heparin, and the plasma was separated by centrifugation and stored at Ϫ20°C. Umbilical vein blood was used to facilitate ease of collection because we have previously shown similar values of EPO in blood drawn separately from the umbilical artery and vein. 19 EPO levels were later measured in duplicate with an enzyme-linked immunosorbent assay kit (Quantikine IVD; R & D Systems, Minneapolis, MN), which is based on the doubleantibody sandwich method and a monoclonal antibody, as described previously. 19 EPO results are given as mean Ϯ SEM in mIU/ml. The intra-assay coefficient of variation was less than 5%, and the interassay coefficient of variation was less than 10%. Apgar scores were assessed by pediatricians or trained labor room nurses.
Statistical analysis was performed using one-way analysis of variance where p values Ͻ 0.05 were considered significant. Post hoc analysis was performed using the Bonferroni method for multiple comparison. Pearson's -squared analysis was used to compare cesarean section rates among the subgroups. The median test was used for multiple comparisons between Apgar scores. Table 1 shows the characteristics of the four subgroups. As expected, the fetal weight is lower in the two groups with FGR and the cesarean section rate is lowest in the normal group.
RESULTS
Compared with AGA infants with normal FHR tracings (controls), mean umbilical cord plasma EPO levels were significantly elevated in all infants with FGR and in all infants with abnormal FHR tracings in labor. Apgar scores at 1 and 5 minutes and cord blood gases were significantly different only in infants with abnormal FHR tracings. Thus, in the FGR group with normal FHR, only the EPO levels were different from those in the controls (Table 2 ). Figure 1 shows the fetal EPO levels (log scale) in the four subgroups. Although there was some overlap, 40% to 60% of the EPO values in the subgroups with FGR or abnormal FHR tracings were higher than the maximum EPO levels seen in the controls. In the FGR with normal FHR tracings, seven neonates had elevated EPO levels. Comparisons between these and the nine other neonates with normal EPO levels showed no difference in median 1-minute Apgar scores (7 vs 7), median 5-minute Apgar scores (9 vs 9), mean umbilical cord pH (7.28 vs 7.26), mean base deficit (Ϫ3 vs Ϫ3), and mean PO 2 levels (19 vs 26), respectively.
DISCUSSION
Chronic intrauterine fetal hypoxia has been suspected as a risk factor for end organ damage and neurologic deficits in the newborn. Although FGR has been associated with long-term neurologic deficit and cerebral palsy, [21] [22] [23] [24] [25] [26] acute or subacute fetal stress in labor only accounts for approximately 10% 4, 6, 11 of all long-term neurologic deficits. Although the institution of continuous electronic fetal heart monitoring has decreased the incidence of acute fetal hypoxia, due to prompt intervention by the obstetrician with rapid delivery, 27 it has had little effect on the incidence of cerebral palsy. 4, 5 This supports the concept that chronic intrauterine hypoxia is a more important factor in the etiology of long-term neurologic deficits. As a result, the search continues for markers of chronic hypoxia that would better identify neonates at risk for organ damage.
EPO production is increased 10-to 100-fold in response to hypoxia. 14 -16,18,19 Studies in the hypobaric chambers in adult humans 28 and rabbits 29 have shown a prompt rise in the EPO levels after a few hours of hypoxia. In experiments with fetal rats 30 and sheep, 31,32 a significant rise in EPO levels was observed after a few hours of hypoxia. The half-life of EPO in human adults 28 is over 5 hours and in newborns is over 3 hours. 33 Molecular genetic techniques have identified DNA sequences in close proximity to the EPO gene that regulate transcription in response to hypoxia. 34, 35 The effects of hypoxia on EPO production is dependent on the de novo translation of these proteins as shown with specific inhibitors of protein synthesis. 35 A search of the literature from 1970 to the present did not reveal any other known stimulator of EPO production independent of hypoxia.
Our results show that mean fetal EPO was elevated in AGA neonates with abnormal FHR tracings and in FGR neonates with and without abnormal FHR tracings (Table 2) . However, Apgar scores and cord blood gases were abnormal only in neonates with abnormal FHR tracings. The amount of overlap between the EPO levels from AGA infants with normal FHR tracings and those of the other three subgroups (Figure 1 ) is expected because not all fetuses in these categories have had prolonged and sustained intrauterine hypoxia. The normal Apgar scores and umbilical cord blood gases in FGR neonates with normal FHR tracings indicate that these are poor indices of chronic fetal hypoxia. The elevated EPO levels in this group emphasize that umbilical cord EPO is a better marker for long-standing intrauterine hypoxia.
From our results, it may appear surprising that the group with FGR and fetal stress did not have a much higher EPO level than that of the other two hypoxic subgroups. There are two explanations for this, first there is a limit to EPO response beyond which there is no further rise in plasma levels like other endocrine organs. Second, animal studies have shown a large fetal EPO response to initial hypoxia with a subsequent return of EPO levels to an intermediate level, which is not as high as the initial response but is higher than the normal baseline level.
Previous studies support our findings. In a group of 75 children with cerebral palsy, Sheilds and Schifrin 14 reported that cord blood acidosis was absent in newborns with chronic hypoxia who did not have intrapartum evidence of fetal distress. Among these children, only half had a low 5-minute Apgar score. Manticoglou et al. 7 reported two cases of severe brain injury without intrapartum evidence of asphyxia or abnormalities in cord blood gases. Ruth et al. 36 reported an association between elevated cord plasma EPO and longterm neurologic deficit in the newborn. These reports reinforce the concept that cord blood gases and Apgar scores are poor markers for chronic intrauterine hypoxia and its resulting end organ damage.
On the other hand, our results show that mean fetal EPO is elevated in all cases of fetal hypoxia, both acute and chronic. Elevated cord EPO in neonates with normal Apgar scores and cord blood gases would suggest chronic hypoxic stress. Although these newborns appear normal in the delivery room, they may be at high risk for neurologic deficits due to intrauterine hypoxia, which was initiated long before the time of labor and delivery. As in the case of intrauterine growth restriction, the likely etiology of elevated EPO in this group would be uteroplacental insufficiency.
In conclusion, the data presented here provide further evidence for the potential usefulness of umbilical cord EPO measurements to identify newborns with intrauterine hypoxia. In conjunction with cord blood gases and Apgar scores, obstetricians and pediatricians may identify newborns who had in utero chronic hypoxia unrelated to intrapartum events. Long-term studies are needed to test the predictive accuracy of umbilical cord EPO levels in determining risks for developmental disabilities in children.
